The application of innovative nanotechnologies to medicine “nanomedicine” has the potential to
significantly benefit clinical practice, offering solutions to many of the current limitations in diagnosis,
treatment and management of human disease.1
Among nanotechnology-derived nanoparticles, carbon nanotubes (CNTs) have stimulated a great interest
for biomedical applications because of their unique mechanical, electrical, thermal and spectroscopic
properties.2
In this work, I will present some of the main advances in the functionalization of carbon nanotubes with
carbohydrates and its potential application as antibacterial activity. On the other hand, the development of
new nanomaterial (GNS) as a potent nanovector of the anticancer drug camptothecin (CPT) will be
presented and comparative results of in vitro activity of their inclusion complex (GNS/CPT) as
nanoparticle-based drug delivery systems of 3rd generation for the controlled delivery of CPT in the
inhibition of carcinogenic cell proliferation.3
المؤتمر
عنوان المؤتمر
The 15th Scientific Congress of the Jordanian Pharmacists Association